A phase 2 study (DisTinGuish) of DKN-01 in combination with tislelizumab plus chemotherapy as first-line (1L) therapy in patients with advanced gastric or GEJ adenocarcinoma (GEA) Meeting Abstract

cited authors

  • Klempner, Samuel J.; Sonbol, Bassam Bassam; Wainberg, Zev A.; Uronis, Hope Elizabeth; Chiu, Vi Kien; Scott, Aaron James; Iqbal, Syma; Tejani, Mohamedtaki Abdulaziz; Stilian, Melissa C.; Thoma, Mathis; Kagey, Michael; Baum, Jason; Sirard, Cynthia A.; Altura, Rachel A.; Ajani, Jaffer A.

Publication Date

  • June 1, 2023

webpage

published in

category

volume

  • 41

issue

  • 16